74 related articles for article (PubMed ID: 8326678)
1. [A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido].
Takeda T; Hatae Y; Nakadate H; Fujita K; Suzuki Y; Wagatsuma Y; Kon-No M; Takase A; Takahashi Y; Nagashima T
Jpn J Antibiot; 1993 May; 46(5):388-96. PubMed ID: 8326678
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of imipenem/cilastatin sodium against severe infections complicating hematological disorders and solid tumors].
Saito H; Furuta S; Nagata A; Yoshizawa S; Nishizawa K; Ichikawa S; Aizawa T; Yoda H; Maruyama D; Koike Y
Jpn J Antibiot; 1991 Aug; 44(8):899-911. PubMed ID: 1920815
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of imipenem/cilastatin sodium against infections in compromised children (malignancy, hematological disease, collagen disease)].
Nakano T; Itoh M; Sakurai M
Jpn J Antibiot; 1992 Aug; 45(8):1016-22. PubMed ID: 1433890
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
Sawae Y; Niho Y; Harada M; Shibuya T; Okamura T; Asano Y; Taniguchi S; Murakawa M; Toyoshima T; Kozuru M
Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
Naito K; Kobayashi M; Okumura M; Ikeda Y; Mitomo Y; Oguri T; Tanaka M; Ohara K; Kodera Y; Ohno R
Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group].
Matsuda S; Suzuki M; Oh K; Ishikawa M; Soma A; Takada H; Shimizu T; Makinoda S; Fujimoto S; Chimura T
Jpn J Antibiot; 1988 Nov; 41(11):1731-41. PubMed ID: 3062205
[TBL] [Abstract][Full Text] [Related]
7. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
Hotta T; Morishima Y; Saito H; Kodera Y; Hirabayashi N; Tanaka M; Mizuno H; Suzuki H; Kato Y; Morishita Y
Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and clinical efficacy of imipenem/cilastatin sodium in neonates].
Azagami S; Kusumoto Y; Oikawa T; Osano M; Shiro H; Shirai Y; Nakamura M
Jpn J Antibiot; 1988 Nov; 41(11):1704-14. PubMed ID: 3210302
[TBL] [Abstract][Full Text] [Related]
9. [A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
Sakata Y; Sawada Y; Kuroe K; Nakaji S; Takami H; Tsushima K; Saito S; Ogasawara H; Shinagawa H; Soma N
Jpn J Antibiot; 1992 Aug; 45(8):1009-15. PubMed ID: 1433889
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group].
Fujii R; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Hashira S; Tajima T; Nakazawa S; Sato H
Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
Tsuda S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Horiike S; Taniwaki M; Misawa S; Kashima K
Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy with imipenem/cilastatin for severe infections accompanied by malignant hematological disorders].
Fujii Y; Inoue Y; Hiroshige Y; Kaku K; Kaneko T
Jpn J Antibiot; 1993 Mar; 46(3):259-68. PubMed ID: 8510323
[TBL] [Abstract][Full Text] [Related]
13. [Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections].
Takamoto M; Ishibashi T; Toyoshima H; Tanaka H; Tamaru N; Watanabe K; Yoshida M; Tokunaga N; Ichikawa Y; Oizumi K
Jpn J Antibiot; 1994 Sep; 47(9):1131-44. PubMed ID: 7990255
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a combination treatment using imipenem/cilastatin sodium with G-CSF on infections in neutropenic patients with hematological malignancies].
Sawada H; Sasada M; Tajima M; Yamamoto K; Yasuda N; Omori S; Yumoto Y; Ishibashi T; Okada H; Suzuki T
Jpn J Antibiot; 1995 Feb; 48(2):271-7. PubMed ID: 7538179
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pharmacokinetic evaluation of imipenem/cilastatin sodium in neonates and young infants].
Sakata H; Kakehashi H; Fujita K; Murono K; Kaeriyama M; Oka T; Yoshioka H; Sasaki N; Mori Y; Maruyama S
Jpn J Antibiot; 1988 Nov; 41(11):1650-6. PubMed ID: 3210299
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of imipenem/cilastatin sodium in serious infections in critical care medical center].
Sakata I; Maruyama J; Takahashi H; Kitagishi H; Nakaji M; Yoshinobu H; Mantani Y; Maruyama K; Iwaki H; Matsushima T
Jpn J Antibiot; 1993 May; 46(5):397-403. PubMed ID: 8326679
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies on imipenem/cilastatin sodium in perinatal use].
Chimura T; Morisaki N; Hirayama T; Matsuo M
Jpn J Antibiot; 1988 Nov; 41(11):1751-7. PubMed ID: 3210306
[TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical evaluation of imipenem/cilastatin sodium in the perinatal period].
Ito K; Izumi K; Takagi H; Tamaya T; Hayasaki M
Jpn J Antibiot; 1988 Nov; 41(11):1778-85. PubMed ID: 3210308
[TBL] [Abstract][Full Text] [Related]
19. [Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
Sawae Y; Niho Y; Okamura T; Gondo H; Kozuru M; Uike N; Muta K; Goto T; Suehiro Y; Kumakawa M; Nishimura J; Yufu Y; Ishikura H; Yamashita S; Hisano S; Morioka E; Nakajima H; Shibuya T; Yamasaki K; Harada N; Asayama R; Hayashi S; Akashi K; Suematsu E; Kawasaki C
Jpn J Antibiot; 1996 Dec; 49(12):1049-61. PubMed ID: 9032592
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of imipenem/cilastatin sodium in the perinatal period].
Yamamoto T; Yasuda J; Kanao M; Okada H
Jpn J Antibiot; 1988 Nov; 41(11):1792-6. PubMed ID: 3210310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
